Heart Health
Beyond statins: New medicines for hard-to-manage cholesterol
 People with an inherited condition thatcauses very high cholesterol levels will likely be the first group of individuals to be offered treatment with PCSK9 inhibitors. Image: Thinkstock |
A novel class of drugs has the potential to pick up the slack where other cholesterol medications leave off.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Print This Page
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
